Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04786106 · ClinicalTrials.gov registry record · Phase 4

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

A Phase 4 study of Peyronie's Disease, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

Active
Registry status
Phase 4
Development phase
40
Enrollment target
1
Study location

NCT04786106: Active Phase 4 study of Peyronie's Disease, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

NCT04786106 is a Phase 4 study of Peyronie's Disease that is active but no longer recruiting, run by Charitable Union for the Research and Education of Peyronie's Disease. The registered enrollment target is 40 participants, below the 182-participant average among 5 other Peyronie's Disease trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04786106, a Phase 4 study of Peyronie's Disease, is active but no longer recruiting, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare key clinical outcomes of collagenase clostridium histolyticum injections versus surgery for the management of Peyronie's Disease.

Primary Outcome

Answer to SAPS question #1 (How satisfied are you with the effect of your treatment?) to determine overall satisfaction at all time points

Conditions Studied

Peyronie's Disease

Interventions

  • DRUG Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex] (CCH)
  • PROCEDURE Penile Plication Surgery
  • PROCEDURE Incision and Grafting (I&G) Surgery
  • DEVICE RestoreX Penile Traction Device

Study Locations (1)

Utah

  • The Male Fertility and Peyronie's Clinic - Orem

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-12-30
Est. Completion 2027-02-15
Phase Phase 4
Charitable Union for the Research and Education of Peyronie's Disease

6 total trials

What the registry record for NCT04786106 still lists

NCT04786106 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 182-participant average among 5 other Peyronie's Disease trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Peyronie's Disease appearing as the primary indexed condition, and to 4 interventions - of which Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex] (CCH) is the first listed.

NCT04786106 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT04786106 about?

NCT04786106 is a clinical study titled "Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's". The purpose of this study is to compare key clinical outcomes of collagenase clostridium histolyticum injections versus surgery for the management of Peyronie's Disease.

What is the current status of trial NCT04786106?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2020-12-30. Estimated completion is 2027-02-15.

What conditions does trial NCT04786106 study?

This clinical trial studies the following conditions: Peyronie's Disease.

What interventions are being tested in trial NCT04786106?

The interventions under investigation include: Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex] (CCH) (DRUG), Penile Plication Surgery (PROCEDURE), Incision and Grafting (I&G) Surgery (PROCEDURE), RestoreX Penile Traction Device (DEVICE).

Who is sponsoring clinical trial NCT04786106?

This trial is sponsored by Charitable Union for the Research and Education of Peyronie's Disease, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04786106 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peyronie's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04786106, the US trial registry maintained by the National Library of Medicine. NCT04786106 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.